Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Excellent treatment compliance reported for AERx(R) iDMS among diabetic patients

June 25, 2003

Rapid onset of action reported for a novel insulin analogue

June 25, 2003

Good safety profile and improved glycemic control reported for balaglitazone in type 2 diabetes

June 25, 2003

Nippon Chemiphar patent covers new xanthine oxidase inhibitors for use in gout and hyperuricemia

June 23, 2003

Novel antiobesity MCH antagonists in early development at Schering-Plough

June 23, 2003

Ezetimibe approved in Canada

June 23, 2003

MCH1 antagonist reduces body weight gain by decreasing food intake

June 23, 2003

NN-2211 improves glycemia and sensitivity to glucose in patients with type 2 diabetes

June 23, 2003

Two studies confirm the potential benefits of NN-414 in type 2 diabetes

June 23, 2003

Improved glycemic control with inhaled insulin compared to rosiglitazone in type 2 diabetics

June 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...